Table of Contents Table of Contents
Previous Page  9 / 398 Next Page
Information
Show Menu
Previous Page 9 / 398 Next Page
Page Background

4

Abstracts

surgical exposure of the orbital floor, the chance of a postoperative

eyelid deformity can be obviated.

Studies have shown that reconstruction of the internal orbit is

unnecessary in a considerable percentage of ZMC fractures. The

big question, however, is how does one decide about the need for

internal orbital reconstruction when a patient presents with a ZMC

fracture?

This lecture will discuss using either the pre-treatment com-

puted tomography (CT) scan or an intraoperative CT scan in

making this determination. Treatment algorithms will be presented

that can be used to sequentially treat many ZMC fractures with the

goal of doing as little surgery as is absolutely necessary to attain

a satisfactory outcome.

http://dx.doi.org/10.1016/j.ijom.2017.02.011

Current concepts in the craniofacial surgery

G.E. Ghali

LSU Health Sciences Center Shreveport, LA, United States

The past quarter of a century has seen significant advances in

craniofacial surgery. These advances range from improvements

in diagnosis to resorbable technology to bone cements and mor-

phogenic proteins.

This presentation will provide an overview of the common

craniofacial and cleft deformities, along with their contemporary

management with an emphasis on both skeletal and soft tissue

correction.

http://dx.doi.org/10.1016/j.ijom.2017.02.012

Facial ballistic injuries — our experience from Afghanistan

and Iraq

S. Parmar

University Hospital Birmingham, Birmingham, United Kingdom

Ballistic injuries are rare in the United Kingdom compared to

many other countries. The Centre for Defence Medicine for the

United Kingdom centralised the treatment of all casualties from

conflicts to the University Hospital Birmingham. This resulted

in a rapid learning curve for the treatment of these high-energy

avulsive injuries during the Iraq and Afghanistan conflicts.

We present our algorithm for the treatment of these complex

injuries.

http://dx.doi.org/10.1016/j.ijom.2017.02.013

Navigation-guided oral and maxillofacial surgery

S.G.F. Shen

Shanghai Ninth People’s Hospital, Shanghai Jiaotong

University School of Medicine, Shanghai, China

The anatomic complexity with the most important vital organs

in the head and neck region remains a big challenge for oral

and maxillofacial surgeons. With the great and fast development

of computer technologies, navigation-guided surgery has been

widely used for minimising the risks and improving the precision

of the maxillofacial surgery.

The aimof this presentation is to provide a current development

of navigation-guided oral and maxillofacial surgery including sur-

gical planning, simulation and navigation in tumour resection,

reconstruction of mandibular or maxillary defects, correction of

posttraumatic deformity and developmental jaw deformity and so

on. Compared with the traditional oral and maxillofacial surgery,

navigation-guided surgery improves quality of operation in preci-

sion and overcomes the disadvantages that majority of surgeons

encounter when performing conventional operations.

http://dx.doi.org/10.1016/j.ijom.2017.02.014

Skeletal surgery for mandibulofacial dysostosis (Treacher

Collins, Nager Syndrome)

T.A. Turvey

University of North Carolina, Chapel Hill, NC, United States

Mandibulofacial dysostosis is a relatively rare autosomal dom-

inant facial clefting disorder effecting about 1 in 50,000 live births.

The expression of the condition is variable and involves both soft

tissue and bone of the face primarily in the periorbital region and

the lower facial regions. The condition is always bilateral but never

symmetrical.

Shortly after birth two issues must be addressed: protection

of vision and preservation of the airway. Protection of vision is

more associated with eyelid competency but airway preservation

may involve mandibular advancement via distraction osteogenesis

or conventional osteotomies, depending on bone stock. Perior-

bital construction is usually directed toward bone grafting of

the zygomas, lateral and inferior orbit prior to soft tissue con-

struction and this is normally deferred until age 7–10 years.

Genioplasty is always beneficial and can be performed once the

mandibular cuspids are no longer at risk. Definitive orthognathic

surgery including orthodontic treatment usually occurs between

14–17 years, depending on the patient’s and parents’ wishes. This

usually involves zygomatico-orbital augmentation, bimaxillary

osteotomies with counter-clockwise rotation of the anterior face

and elongation of the posterior face. Genioplasty can be redone as

needed.

The final phase of treatment includes soft tissue procedures

such as fat grafting or other soft tissue transfer surgical procedures.

http://dx.doi.org/10.1016/j.ijom.2017.02.015

Plenary 2: Pathology, Oncology and Reconstructive

Surgery

Immunotherapy for head and neck cancer: integrating the

fourth modality into treatment

R.B. Bell

Providence Cancer Center, Portland, OR, United States

The practice of oncology is being transformed as a result of

our understanding that the presence of an endogenous anticancer

immune response prior to treatment plays an important prognostic

role in the long-term therapeutic effects seen following conven-

tional therapy as well as immunotherapy. Adoptive cell transfer

with tumour infiltrating lymphocytes or receptor-engineered T

cells, as well as checkpoint inhibitors, such as cytotoxic T lympho-

cyte antigen-4 (CTLA-4) anti-programmed death-1 (anti PD-1),

that function by taking the brakes off pre-existing anticancer

immunity are resulting in objective clinical responses or durable

stable disease in patients with a wide spectrum of cancers.

Collectively, the success of immunotherapy has lead tomultiple

Federal Drug Administration (FDA) approvals in numerous indi-

cations and has catapulted the status of this modality into standard

of care for patients with metastatic melanoma, non-small cell lung